
How does Alzheimer's disease affect the whole body?
Research shows that Alzheimer's disease affects many organs beyond the nervous system.Alzheimer's is characterized by a buildup of proteins in the brain, which disrupts their function.
A new study in fruit flies shows that these proteins may also significantly impact the functioning of other organs.
The researchers also identified mechanisms that might explain how proteins in the brain can have such wide-reaching effects.
A new study in fruit flies concludes that proteins associated with Alzheimer's disease not only influence brain health, but also have effects further afield.
Specifically, the researchers show that certain Alzheimer's-associated proteins can increase the rate of biological aging and influence fat metabolism and reproduction.
They also created an Alzheimer's Disease Fly Cell Atlas (AD-FCA) based on their analysis of 219 cell types in flies that express Alzheimer's-associated proteins in their brains.
The results recently appeared in the journal Neuron .
Alzheimer's and other dementias are considered diseases of the mind, and for good reason. The primary symptoms are cognitive changes that grow progressively more severe as time goes on.
For this reason, much of the research into dementia focuses on the brain and nervous system. However, more recently, scientists have begun exploring Alzheimer's influence on other aspects of the body.
The authors of the new study explain how new evidence hints that the effects of Alzheimer's extend beyond the nervous system to other parts of the body. 'For example,' they write, Alzheimer's 'has been associated with disruptions in the gut microbiota, cardiovascular function, and hormone homeostasis.'
Alzheimer's disease is characterized by a buildup of faulty proteins in the brain, including amyloid-beta 42 and tau.
As they accumulate, they form so-called amyloid plaques and neurofibrillary tangles, respectively. These proteins interfere with how neurons work and, eventually, kill them.
In their recent study, the researchers used fruit flies. Although fruit flies, as you may have noticed, are quite different from humans, they have already provided many insights into human health.
As the researchers write, 'Many molecular pathways are conserved from flies to mammals.'
Medical News Today contacted Gurneet Sawhney, MD, chief neurosurgeon and founder at Neurolife Brain and Spine Clinic, who was not involved in the study. We asked about the usefulness of fly models in neuroscience.
'Fruit fly models are surprisingly valuable in dementia research. While they may seem simplistic,' he explained, 'they allow us to study the effects of tau and amyloid at a genetic and cellular level, with faster results and lower complexity than mammalian models.'
'They've helped us uncover fundamental mechanisms of neurodegeneration that often translate into mammalian systems later,' he said.
In the current experiment, the scientists used flies with either amyloid or tau buildup and compared them with control flies without protein buildup.
The researchers employed a technique called whole-organism single-nucleus RNA sequencing . In a nutshell, this involves analyzing genetic information from cell nuclei to discover which genes are turned 'on' in specific cell types.
The authors investigated the impact of tau and amyloid on a range of cell types throughout the flies' bodies.
First, they examined the cells of the nervous system, including brain cells, nerve cells in their body, and glial cells (support cells for neurons).
They found that amyloid resulted in the loss of many types of these cells compared with tau and control flies.
In particular, cells involved with the senses, such as vision, hearing, and smell, were impacted most severely. Interestingly, loss of smell is an early sign of Alzheimer's in humans.
When investigating the mechanism responsible for neuronal cell death, the researchers identified a cluster of neuronal cells that expressed lactate dehydrogenase (LDH). We asked Sawhney why this matters:
'LDH plays a role in cellular energy metabolism,' he explained, 'and its dysregulation can indicate tissue stress or damage. In the context of dementia, abnormal LDH activity might reflect broader metabolic dysfunction.'
Importantly, the scientists also identified increased levels of LDH in the brain tissue from humans with Alzheimer's but not those without the condition. According to Sawhney, this increased LDH may 'link neurodegeneration with systemic effects, as this study hints.'
The scientists also showed that cells with elevated LDH had changes in genes that control mitochondrial functions. This is important because mitochondrial dysfunction is linked to oxidative stress, which is an early feature of Alzheimer's in humans.
Next, the scientists moved their attention to the effects of Alzheimer's proteins on cells other than those of the nervous system. This time, it was tau that produced the most significant changes.
The cell types that were most affected were those involved in fat metabolism, digestion, and reproduction. According to the authors, 'The fly fat body is a central storage depot of nutrients and energy reserves.' It carries out a similar role to the liver, immune system, and fat tissue in mammals.
They found that fat droplets in tau flies are large early on, but become smaller and more fragmented as the disease progresses. The researchers then looked at fat cells in a mouse model of Alzheimer's — the equivalent of the fly's fat droplets. Again, they found oversized fat cells initially, which grew smaller as the disease progressed.
Aside from changes in fat metabolism, the researchers noted changes in the behaviour of cells in the gut. In line with this, studies in mice have also shown that tau induces gut degeneration .
Finally, neuronal tau was associated with a reduced ability to reproduce in male flies. In concordance with this, studies show that a decline in sex hormones is associated with an increased risk of Alzheimer's in humans.
According to the authors, changes in fat metabolism, digestion, and reproduction are associated with aging. So, the authors hypothesize that tau's presence in neurons may increase the speed of aging throughout the rest of the body.
By measuring gene expression and molecular markers associated with fly aging, the scientists found that tau flies, but not amyloid or control flies, aged more quickly.
Overall, they conclude that 'Tau expression has a broad impact on peripheral tissues and induces an accelerated aging phenotype.'
To understand how tau in neurons has such wide-ranging effects on the body, the scientists used cell-cell communication analysis, which can identify changes in how the brain communicates with the body.
Compared with amyloid and control flies, tau flies demonstrated thousands of differences in these communication pathways. The cell types showing the greatest differences, once again, were involved with fat metabolism, digestion, and reproduction.
These results suggest that tau in the brain can influence cells in the rest of the body by interfering with brain-body communication.
Investigating further, they found that in neurons containing tau, there were changes in the gene expression that affected how synapses — the junction between nerve cells — are organized.
There were also increased levels of synaptic boutons in the gut of tau flies. The synaptic boutons are swellings on nerves at the synapse that contain neurotransmitters, which pass information from one neuron to another.
In other words, tau in brain cells can influence not only how neurons work and develop within the brain but also how effectively they communicate with more distant tissues.
Overall, the scientists conclude that while amyloid and tau are both toxic, their effects are distinct: Amyloid predominantly affects neurons, and tau has a more widespread impact on the body.
They also found that LDH is elevated in amyloid flies, as well as in mice and humans with Alzheimer's. They believe this should be an area for future research, as LDH could perhaps be used as an early biomarker for Alzheimer's.
Research on flies is an important first step in scientific research; it provides direction for future studies on other animals and, eventually, humans.
While we need to interpret the results with caution, taken together, they provide new insights into the widespread effects of Alzheimer's-associated proteins.
'The focus on the peripheral effects of tau and amyloid stands out in this study,' Sawhney told MNT .
'We often think of these proteins as brain-specific problems, but this work highlights how their impact may extend beyond the central nervous system. That's an important shift in perspective for understanding the full systemic nature of dementia.'
— Gurneet Sawhney, MD
Alzheimer's / Dementia
Neurology / Neuroscience
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


North Wales Chronicle
8 minutes ago
- North Wales Chronicle
Abortion pioneer died at 93 in hospital after being diagnosed with dementia
Dr Horace Hale Harvey III, who was born in New Orleans in December 1931, opened one of the first independent abortion clinics in the US in Manhattan in July 1970 after New York State had reformed its laws. The clinic, called Women's Services, provided safe and affordable abortions. In an obituary, the New York Times reported that Dr Harvey had become an abortion provider to 'combat what he felt was an epidemic of unsafe abortions at a time when unmarried women were denied access to contraceptives, and when comprehensive sex education was discouraged'. Dr Harvey, who had a son and a daughter, later moved to the Isle of Wight and worked for public health services there but in 2014 moved to Dorset after his house burned down. The obituary states that Dr Harvey had chosen the Isle of Wight because 'according to his research, it had the highest average temperature and received more hours of sunlight than anywhere else in England'. In a statement read to the Bournemouth inquest, his daughter Kate said that her father was 'very determined' to keep healthy by walking a mile and doing 20 squats each day and said he 'enjoyed laughter and making up jokes' as well as activities such as dance, table tennis and snooker. She added that he was a scholar who was 'committed to Aristotelian ethics and scientific learning'. The inquest heard that in late 2024, Dr Harvey was diagnosed with Alzheimer's and PTSD after the house fire 10 years earlier. On January 22 2025, he was taken to Dorset County Hospital having suffered a rib fracture in a fall at home. After physiotherapists expressed concerns at his ability to understand care instructions, he was assessed by psychiatrists and was detained under the mental health act. Coroner Richard Middleton said that Dr Harvey was increasingly experiencing delirium and paranoia. He said that Dr Harvey was found dead in his hospital bed in the early hours of February 14 and a post-mortem examination found he died of natural causes from ischaemic heart disease and coronary artery disease. The coroner, recording a conclusion of death by natural causes, explained that the inquest had to be held by law because Dr Harvey was formally detained by the state at the time of his death. Mr Middleton added: 'I express my deepest condolences to all of Dr Harvey's family and friends for their loss.'


The Independent
8 minutes ago
- The Independent
States sue Trump, saying he is intimidating hospitals over gender-affirming care for youth
Seventeen Democratic officials accused President Donald Trump 's administration of unlawfully intimidating health care providers into stopping gender-affirming care for transgender youth in a lawsuit filed Friday. The complaint comes after a month in which at least eight major hospitals and hospital systems — all in states where the care is allowed under state law — announced they were stopping or restricting the care. The latest announcement came Thursday from UI Health in Chicago. Trump's administration announced in July that it was sending subpoenas to providers and focusing on investigating them for fraud. It later boasted in a news release that hospitals are halting treatments. The Democratic officials say Trump's policies are an attempt to impose a nationwide ban on the treatment for people under 19 — and that's unlawful because there's no federal statute that bans providing the care to minors. The suit was filed by attorneys general from 15 states and the District of Columbia, plus the governor of Pennsylvania, in U.S. District Court in Boston. 'The federal government is running a cruel and targeted harassment campaign against providers who offer lawful, lifesaving care to children,' New York Attorney General Letitia James said in a statement. Trump and others who oppose the care say that it makes permanent changes that people who receive it could come to regret — and maintain that it's being driven by questionable science. Since 2021, 28 states with Republican-controlled legislatures have adopted policies to ban or restrict gender-affirming care for minors. In June, the U.S. Supreme Court ruled that states have a right to enforce those laws. For families with transgender children, the state laws and medical center policy changes have sparked urgent scrambles for treatment. The medical centers are responding to political and legal pressure The Center for Transyouth Health and Development at Children's Hospital Los Angeles, the biggest public provider of gender-affirming care for children in teens in the U.S., closed in July. At least seven other major hospitals and health systems have made similar announcements, including Children's National in Washington D.C., UChicago Medicine and Yale New Haven Health. Kaiser Permanente, which operates in California and several other states, said it would pause gender-affirming surgeries for those under 19 as of the end of August, but would continue hormone therapy. Connecticut Children's Medical Center cited 'an increasingly complex and evolving landscape" for winding down care. Other hospitals, including Penn State, had already made similar decisions since Trump returned to office in January. Alex Sheldon, executive director of GLMA, an organization that advocates for health care equity for LGBTQ+ people, said the health systems have pulled back the services for legal reasons, not medical ones. 'Not once has a hospital said they are ending care because it is not medically sound,' Sheldon said. Trump's administration has targeted the care in multiple ways Trump devoted a lot of attention to transgender people in his campaign last year as part of a growing pushback from conservatives as transgender people have gained visibility and acceptance on some fronts. Trump criticized gender-affirming care, transgender women in women's sports, and transgender women's use of women's facilities such as restrooms. On his inauguration day in January, Trump signed an executive order defining the sexes as only male and female for government purposes, setting the tone for a cascade of actions that affect transgender people. About a week later, Trump called to stop using federal money, including from Medicaid, for gender-affirming care for those under 19. About half of U.S. adults approve of Trump's handling of transgender issues, an AP-NORC poll found. But the American Medical Association says that gender is on a spectrum, and the group opposes policies that restrict access to gender-affirming health care. Gender-affirming care includes a range of medical and mental health services to support a person's gender identity, including when it's different from the sex they were assigned at birth. It includes counseling and treatment with medications that block puberty, and hormone therapy to produce physical changes, as well as surgery, which is rare for minors. In March, a judge paused enforcement of the ban on government spending for care. The court ruling didn't stop other federal government action In April, Attorney General Pam Bondi directed government investigators to focus on providers who continue to offer gender-affirming care for transgender youth. 'Under my leadership, the Department of Justice will bring these practices to an end," she wrote. In May, the Department of Health and Human Services issued a report discouraging medical interventions for transgender youth and instead focusing solely on talk therapy. The report questions adolescents' capacity to consent to life-changing treatments that could result in future infertility. The administration has not said who wrote the report, which has been deeply criticized by LGBTQ+ advocates. In June, a Justice Department memo called for prioritizing civil investigations of those who provide the treatment. In July, Justice Department announced it had sent more than 20 subpoenas to doctors and clinics involved in gender-affirming care for youth, saying they were part of investigations of health care fraud, false statements and other possible wrongdoing. And in a statement last week, the White House celebrated decisions to end gender-affirming care, which it called a 'barbaric, pseudoscientific practice' Families worry about accessing care Kristen Salvatore's 15-year-old child started hormone therapy late last year at Penn State Health. Salvatore said in an interview with The Associated Press before the lawsuit was announced that it was a major factor in reduced signs of anxiety and depression. Last month, the family received official notice from the health system that it would no longer offer the hormones for patients under 19 after July 31, though talk therapy can continue. Salvatore has been struggling to find a place that's not hours away from their Mechanicsburg, Pennsylvania, home that would provide the hormones and accept Medicaid coverage. 'I'm walking around blind with no guidance, and whatever breadcrumbs I was given are to a dead-end alleyway,' she said. The family has enough testosterone stockpiled to last until January. But if they can't find a new provider by then, Salvatore's child could risk detransitioning, she said.
.jpg%3Ftrim%3D0%2C0%2C0%2C0%26width%3D1200%26height%3D800%26crop%3D1200%3A800&w=3840&q=100)

The Independent
8 minutes ago
- The Independent
Doctor warns of hand symptom that can reveal advanced lung cancer
A Brooklyn doctor warns that a modest transformation in fingernails could indicate lung cancer. Dr. Davood Johari, a pulmonary and critical care specialist at NYC Health + Hospitals/Kings County, told the New York Post that 5 percent to 15 percent of lung cancer patients develop nail clubbing, which typically appears in later stages of the disease, often too late for effective intervention. 'Fingertips appear wider and rounder than normal, with the nails curving downwards, resembling an upside-down spoon,' Johari said as August 1 marks World Lung Cancer Day. 'The nail bed, the area under the nail, feels spongy and softer,' he added. 'The fingertip might be red or feel warmer than usual.' The exact cause of nail clubbing and the connection to lung cancer isn't fully known, but it may result from hormone-like substances produced by tumors that widen blood vessels in the fingers, increasing blood flow and causing fluid buildup under the nails. Lung cancer remains the leading cause of cancer deaths globally, with about 226,650 new U.S. diagnoses expected this year, leading to nearly 125,000 deaths. Johari urges that anyone who notices persistent changes in nail color, shape, or thickness lasting more than two weeks, even without other symptoms to seek medical attention. People with other lung cancer symptoms including a persistent cough, voice changes, unexplained weight loss or fatigue, ongoing shoulder pain that worsens at night, vision issues, or drooping eyelids, should also consult a doctor, he said. Lung cancer evaluations usually start with a medical history review, physical exam and imaging, with a biopsy required for a definitive diagnosis. Nail clubbing can also indicate other serious conditions like chronic lung infections, heart defects, gastrointestinal diseases and autoimmune disorders. Johari said that other nail changes such as dark streaks, persistent bruises, nail lifting or bleeding, may also signal various forms of cancer and shouldn't be ignored. 'Many nail changes are harmless and may be related to aging, injury and trauma or everyday activities like using nail polish,' Johari told the outlet. 'However, any changes in nail color, nail shape or thickness, which are persistent and last for more than a couple of weeks, should be checked by a physician.' While smoking is the most well-known cause of lung cancer, several other risk factors can also lead to the disease. One major cause is radon exposure, a naturally occurring, odorless, colorless and tasteless gas that is the second leading cause of lung cancer in the US, particularly among non-smokers, according to the Ohio State University Comprehensive Cancer Center. High, unsafe levels of radon are commonly found in rock, soil and groundwater. Testing homes for radon and understanding local regulations are key to reducing exposure, and fortunately, high radon levels can often be lowered through effective mitigation. Age is another factor, with two-thirds of lung cancer cases diagnosed in individuals over 65 years old, and most occurring in those over 45, per the source. A family or personal history of lung cancer also increases risk. Additional environmental and occupational exposures, such as to arsenic, asbestos, cadmium, chromium, uranium and certain petroleum products, can contribute to lung cancer development. Air pollution, prior radiation therapy to the chest or breast and a history of lung diseases such as tuberculosis further elevate the risk.